In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening
Biosensors · 2023
DOI: 10.3390/bios13020231 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2023. Verfasst von Huyen Ngo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Quantum Biophysics, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Biological Science Disciplines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HK Lee foundation for the Institute of Quantum Biophysics.
Abstract (Originalsprache)
The evolution of preclinical in vitro cancer models has led to the emergence of human cancer-on-chip or microphysiological analysis platforms (MAPs). Although it has numerous advantages compared to other models, cancer-on-chip technology still faces several challenges such as the complexity of the tumor microenvironment and integrating multiple organs to be widely accepted in cancer research and therapeutics. In this review, we highlight the advancements in cancer-on-chip technology in recapitulating the vital biological features of various cancer types and their applications in life sciences and high-throughput drug screening. We present advances in reconstituting the tumor microenvironment and modeling cancer stages in breast, brain, and other types of cancer. We also discuss the relevance of MAPs in cancer modeling and precision medicine such as effect of flow on cancer growth and the short culture period compared to clinics. The advanced MAPs provide high-throughput platforms with integrated biosensors to monitor real-time cellular responses applied in drug development. We envision that the integrated cancer MAPs has a promising future with regard to cancer research, including cancer biology, drug discovery, and personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Quantum Biophysics, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- Department of Biophysics, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Department of Bioengineering, University of California at Berkeley, Berkeley, CA 94720, USA.
- Department of Electrical Engineering and Computer Science, University of California at Berkeley, Berkeley, CA 94720, USA.
ORCID-Profile: Sarnai Amartumur, Van Thi Ai Tran, Yen N Diep, Hansang Cho, Luke P Lee
Förderung
- HK Lee foundation for the Institute of Quantum Biophysics
Zitieren
APA
Ngo, H., Amartumur, S., Tran, V. T. A., Tran, M., Diep, Y. N., Cho, H., & Lee, L. P. (2023). In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening. Biosensors. https://doi.org/10.3390/bios13020231
Vancouver
Ngo H, Amartumur S, Tran VTA, Tran M, Diep YN, Cho H, et al. In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening. Biosensors. 2023. doi:10.3390/bios13020231
BibTeX
@article{Ngo2023,
author = {Ngo, Huyen and Amartumur, Sarnai and Tran, Van Thi Ai and Tran, Minh and Diep, Yen N and Cho, Hansang and Lee, Luke P},
title = {In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening},
journal = {Biosensors},
year = {2023},
doi = {10.3390/bios13020231}
}
EUVIMED